Medivolve Inc. (MEDVF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 38.25 Thousand CAD | -88.86% |
| 2022 | 343.34 Thousand CAD | -11.65% |
| 2021 | 388.63 Thousand CAD | 66.95% |
| 2020 | 232.78 Thousand CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 100.0% |
| 2014 | -76.33 Thousand CAD | 90.08% |
| 2013 | -769.83 Thousand CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| 2007 | - CAD | 0.0% |
| 2006 | - CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 39.19 Thousand CAD | 2.45% |
| 2023 Q3 | 34.78 Thousand CAD | 76.66% |
| 2023 Q4 | 38.25 Thousand CAD | 9.97% |
| 2023 Q1 | 47.01 Thousand CAD | -86.31% |
| 2023 FY | 38.25 Thousand CAD | -88.86% |
| 2023 Q2 | 19.69 Thousand CAD | -58.12% |
| 2022 Q2 | 372.81 Thousand CAD | -30.29% |
| 2022 Q4 | 343.34 Thousand CAD | -9.48% |
| 2022 Q3 | 379.28 Thousand CAD | 1.74% |
| 2022 FY | 343.34 Thousand CAD | -11.65% |
| 2022 Q1 | 534.77 Thousand CAD | 37.6% |
| 2021 FY | 388.63 Thousand CAD | 66.95% |
| 2021 Q1 | 483.83 Thousand CAD | 107.85% |
| 2021 Q3 | 751.28 Thousand CAD | 94.35% |
| 2021 Q4 | 388.63 Thousand CAD | -48.27% |
| 2021 Q2 | 386.56 Thousand CAD | -20.11% |
| 2020 Q3 | -20.42 Million CAD | -47.73% |
| 2020 FY | 232.78 Thousand CAD | 0.0% |
| 2020 Q1 | -2.17 Million CAD | -27.59% |
| 2020 Q2 | -13.82 Million CAD | -536.76% |
| 2020 Q4 | 232.78 Thousand CAD | 101.14% |
| 2019 Q4 | -1.7 Million CAD | -1.35% |
| 2019 Q2 | -147.95 Thousand CAD | 28.5% |
| 2019 Q3 | -1.67 Million CAD | -1034.83% |
| 2019 Q1 | -206.91 Thousand CAD | -439.21% |
| 2019 FY | - CAD | 0.0% |
| 2018 Q3 | -19.36 Thousand CAD | 65.43% |
| 2018 Q2 | -56.02 Thousand CAD | 86.43% |
| 2018 Q1 | -412.99 Thousand CAD | -2.47% |
| 2018 FY | - CAD | 0.0% |
| 2018 Q4 | -38.37 Thousand CAD | -98.12% |
| 2017 Q1 | -193.54 Thousand CAD | -58.16% |
| 2017 Q3 | -68.34 Thousand CAD | 45.8% |
| 2017 Q4 | -403.04 Thousand CAD | -489.74% |
| 2017 Q2 | -126.1 Thousand CAD | 34.85% |
| 2017 FY | - CAD | 0.0% |
| 2016 Q4 | -122.37 Thousand CAD | 13.61% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q1 | -56.59 Thousand CAD | -32.99% |
| 2016 Q2 | -117.1 Thousand CAD | -106.92% |
| 2016 Q3 | -141.65 Thousand CAD | -20.96% |
| 2015 Q4 | -42.55 Thousand CAD | 30.59% |
| 2015 Q2 | 8155.00 CAD | 107.66% |
| 2015 Q1 | -106.5 Thousand CAD | -39.53% |
| 2015 FY | - CAD | 100.0% |
| 2015 Q3 | -61.31 Thousand CAD | -851.87% |
| 2014 Q3 | -342.94 Thousand CAD | -115.89% |
| 2014 Q1 | -539.02 Thousand CAD | 29.98% |
| 2014 FY | -76.33 Thousand CAD | 90.08% |
| 2014 Q2 | -158.85 Thousand CAD | 70.53% |
| 2014 Q4 | -76.33 Thousand CAD | 77.74% |
| 2013 Q4 | -769.83 Thousand CAD | -27.85% |
| 2013 FY | -769.83 Thousand CAD | 0.0% |
| 2013 Q3 | -602.12 Thousand CAD | -2131.06% |
| 2013 Q2 | 29.64 Thousand CAD | 106.97% |
| 2013 Q1 | -425.16 Thousand CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2008 Q2 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2007 Q1 | - CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2007 Q4 | - CAD | 0.0% |
| 2007 FY | - CAD | 0.0% |
| 2006 FY | - CAD | 0.0% |
| 2006 Q4 | - CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Bio Medica Corporation | 379 Thousand USD | 89.906% |
| Arrayit Corporation | 464.19 Thousand USD | 91.759% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 757 Thousand USD | 94.946% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | -2385.00 USD | 1703.983% |
| DermTech, Inc. | 1 Million USD | 96.19% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 3.29 Million USD | 98.84% |
| HTG Molecular Diagnostics, Inc. | 909.32 Thousand USD | 95.793% |
| iMD Companies, Inc. | 38.31 Thousand USD | 0.159% |
| IDenta Corp. | 442.28 Thousand USD | 91.351% |
| Interpace Biosciences, Inc. | 1.22 Million USD | 96.882% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 163.13 Thousand USD | 76.55% |
| Lumos Diagnostics Holdings Limited | 784 Thousand USD | 95.121% |
| Many Bright Ideas Technologies Inc. | -375.00 USD | 10301.333% |
| Medical Imaging Corp. | - USD | -Infinity% |
| NovelStem International Corp. | - USD | -Infinity% |
| Optigenex Inc. | 468.77 Thousand USD | 91.839% |
| PharmChem, Inc. | 391.93 Thousand USD | 90.24% |
| Proteome Sciences plc | 1.06 Million USD | 96.41% |
| Response Genetics, Inc | 133 Thousand USD | 71.237% |
| Rennova Health, Inc. | 242.64 Thousand USD | 84.234% |
| RushNet, Inc. | - USD | -Infinity% |
| ScreenPro Security Inc. | 73.89 Thousand USD | 48.232% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 95.62 Thousand USD | 59.993% |
| Todos Medical Ltd. | 1.02 Million USD | 96.253% |